Who invested in Oyster Point Pharmaceuticals?
Oyster Point Pharmaceuticals's investors include New Enterprise Associates, Versant Ventures and Invus.
Who invested in Oyster Point Pharmaceuticals
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$121Mraised across 1 round since 2020, from 1 source
- Latest round
- Round, $121MMay 2020
- Investors
- 3
The rounds
- May 2020
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Oyster Point Pharmaceuticals
How much has Oyster Point Pharmaceuticals raised?
Oyster Point Pharmaceuticals has raised $121M across 1 round since 2020.
When did Oyster Point Pharmaceuticals last raise?
Oyster Point Pharmaceuticals's most recent round was an Undisclosed round of $121M in May 2020.
What was Oyster Point Pharmaceuticals's biggest round?
Its most recent round, $121M in May 2020, is also its largest on record.
Who backed Oyster Point Pharmaceuticals first?
Oyster Point Pharmaceuticals's first round on record, in May 2020, was backed by New Enterprise Associates, Versant Ventures and Invus.
What stage is Oyster Point Pharmaceuticals at?
Oyster Point Pharmaceuticals's latest named round is an Undisclosed round, in May 2020.
Companies like Oyster Point Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.